Ms. Kathy wants to share this Medical News Today. Ms. Kathy saw this article on the Medical News Today website and thought you might be interested in it:
************************************************************
Potentia Pharmaceuticals' POT-4 Drug Candidate For Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial
Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of Intravitreal POT-4 Therapy for Patients with Neovascular Age-Related Macular Degeneration) clinical trial for the company's leading drug candidate, POT-4...
To read the full article, please go to:
http://www.medicalnewstoday.com/articles/148725.php
************************************************************
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.